Tag: intellipharmaceutics

March 9, 2018

Luminor Medical Technologies Changes Its Name to RISE Life Science Corp.

Luminor Medical Technologies (TSXV:LMT), further to the acquisition of RISE Research Inc., announced today that it changed its corporate name...
January 24, 2018

Intellipharmaceutics Provides Operational Update

Intellipharmaceutics International (Nasdaq:IPCI) a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- and targeted-release...
December 13, 2017

5 Top Pharmaceutical Stories of 2017

Here are the five top stories that caught the attention of our investor audience in the pharmaceutical business during 2017.
September 1, 2017

Intellipharmaceutics Appoints New Chief Financial Officer

Intellipharmaceutics International announced the appointment of a new Chief Financial Officer.
April 10, 2017

Intellipharmaceutics To Challenge Patent Lawsuit

Intellipharmaceutics International is facing legal action related to a patent infringement case from Purdue Pharma.
March 20, 2017

Intellipharmaceutics Talks Abuse Deterrent Technologies

INN sat down with Intellipharmaceutics' CEO Dr. Isa Odidi, to talk about its abuse deterrent technologies and product pipeline.
February 10, 2017

Intellipharmaceutics Announces 2016 Year End Results

TORONTO, Feb. 10, 2017 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing...